Oncogene 25 (16), 23042317
Acta reduciendo el apetito, retrasando el vaciamiento gstrico y mejorando la sensibilidad a la insulina, no como termognico directo
FDA prescribing information for EGRIFTA WR identifies tesamorelin as a therapy for reducing excess abdominal fat in adults with HIV-associated lipodystrophy and states that it is not indicated for weight-loss management
Vitamin C is particularly effective at boosting collagen production and protecting against UV damage
Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, meaning it mimics the actions of two naturally occurring incretin hormones that regulate blood sugar, appetite, and metabolic health
Regular check-ins allow for real-time adjustments to your treatment plan based on your progress, side effects and changing goals